Bayer HealthCare
-
Bayer HealthCare, Tsinghua University in partnership
Both partners signed a new strategic agreement to collaborate in the area of biomedical sciences over the next three years.
Bayer HealthCare | 07 May 2012
-
Phase III studies with VEGF Trap-Eye in wet age-related macular degeneration show sustained improvement in visual acuity
Bayer HealthCare and Regeneron Pharmaceuticals announced that in an integrated analysis of two parallel Phase III studies (VIEW 1 and VIEW 2) in patients with the neovascular form of age-related macular degeneration (wet AMD), patients treated with VEGF Trap-Eye showed a sustained improvement in visual acuity at 96 weeks versus baseline.
Bayer HealthCare | 25 January 2012
-
Bayer HealthCare sees growth in Asia
Bayer HealthCare Pharmaceuticals has increased its sales in Asia Pacific by 5.8 percent to €604 million (US$860 million) in 2010 compared with 2009. This surpasses the global growth of 0.9 percent. The company is pursuing organic and inorganic …
Bayer HealthCare | 01 May 2011
-
Bayer HealthCare CEO to provide keynote address at BIO China International Conference
The Biotechnology Industry Organization (BIO) announced today that Dr Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote address at the BIO China International Conference to be held October 12-13 in Shanghai, China. The event will bri…
Bayer HealthCare | 20 April 2011
-
Bayer HealthCare sees growth in Asia
Bayer HealthCare Pharmaceuticals has increased its sales in Asia Pacific by 5.8 percent to €604 million (US$860 million) in 2010 compared with 2009. This surpasses the global growth of 0.9 percent. The company is pursuing organic and inorganic …
Bayer HealthCare | 23 March 2011
